Editorial Commentary:Association of Comorbid Asthma and the Efficacy of Bioabsorbable Steroid-eluting Sinus Stents Implanted after Endoscopic Sinus Surgery in Patients with Chronic Rhinosinusitis with Nasal Polyps  

作　　者：Xin LUO Xue-kun HUANG Ya-na ZHANG Qin-tai YANG 

机构地区：[1]Department of Otolaryngology-Head and Neck Surgery,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,510630,China [2]Department of Allergy,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,510630,China [3]Naso-Orbital-Maxilla and Skull Base Center,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,510630,China

出　　处：《Current Medical Science》2023年第6期1258-1259,共2页当代医学科学（英文）

摘　　要：Chronic rhinosinusitis with nasal polyps(CRSw-NP)is a multifactorial and heterogeneous disorder of the sinonasal mucosa,characterized by a high relapse rate after medical and surgical treatments[1].Endoscopic sinus surgery(ESS)is the preferred treatment for CRSwNP in patients who have failed to respond to medical therapy[2].However,the postoperative complications will impair the recovery of patients,and accompanying post-operative outpatient visits may contribute to patient discomfort[3]Suppressing postoperative mucosa edema and improving mucosa recovery is critical to reducing the disease relapse after ESS.The steroid-eluting sinus stent(SESS)represents a promising emerging therapy for CRSwNP.

关 键 词：Surgery operative treatment 

分 类 号：R765.9[医药卫生—耳鼻咽喉科]